Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYXT
3276
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $2.35M | ﹤0.01% |
+254,492
| New | +$2.38M |
|
3277
Crawford & Co Class A
CRD.A
$632M
| $2.35M | ﹤0.01% |
261,890
+5,371
| +2% | +$52.6K |
|
3278
Lakeland Industries
LAKE
$117M
| $2.35M | ﹤0.01% |
111,815
-85
| -0.1% | -$1.98K |
|
|
NVMI
3279
Nova
NVMI
$13.1B
| $2.35M | ﹤0.01% |
22,942
+80
| +0.3% | +$7.93K |
|
3280
Werewolf Therapeutics
HOWL
$18.8M
| $2.34M | ﹤0.01% |
136,472
+28,294
| +26% | +$483K |
|
3281
Caesarstone
CSTE
$105M
| $2.34M | ﹤0.01% |
188,230
-19,539
| -9% | -$262K |
|
3282
Ardelyx
ARDX
$1.01B
| $2.33M | ﹤0.01% |
1,768,308
+323,910
| +22% | +$865K |
|
3283
KVH Industries
KVHI
$143M
| $2.33M | ﹤0.01% |
241,647
-71
| -0% | -$770 |
|
|
RYM
3284
RYTHM Inc
RYM
$48.4M
| $2.33M | ﹤0.01% |
42
+5
| +14% | +$328K |
|
|
TRML
3285
DELISTED
Tourmaline Bio
TRML
| $2.32M | ﹤0.01% |
17,134
+1,728
| +11% | +$237K |
|
|
CWBC
3286
Community West Bancshares
CWBC
$706M
| $2.31M | ﹤0.01% |
107,451
-454
| -0.4% | -$9.79K |
|
|
INZY
3287
DELISTED
Inozyme Pharma
INZY
| $2.3M | ﹤0.01% |
198,624
+18,952
| +11% | +$296K |
|
3288
Ondas Inc
ONDS
$5.08B
| $2.3M | ﹤0.01% |
251,284
+58,576
| +30% | +$445K |
|
|
CDR
3289
DELISTED
Cedar Realty Trust, Inc
CDR
| $2.29M | ﹤0.01% |
105,694
| – | – |
|
|
STER
3290
DELISTED
Sterling Check Corp. Common Stock
STER
| $2.29M | ﹤0.01% |
+88,028
| New | +$2.31M |
|
|
PFHD
3291
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $2.28M | ﹤0.01% |
121,507
+16,574
| +16% | +$315K |
|
3292
Pioneer Bancorp
PBFS
$418M
| $2.28M | ﹤0.01% |
180,502
-308
| -0.2% | -$3.71K |
|
|
SBOW
3293
DELISTED
SilverBow Resources, Inc.
SBOW
| $2.28M | ﹤0.01% |
93,060
-6,764
| -7% | -$137K |
|
3294
Five Star Bancorp
FSBC
$1.16B
| $2.26M | ﹤0.01% |
94,246
+6,542
| +7% | +$157K |
|
3295
Absci
ABSI
$1.62B
| $2.25M | ﹤0.01% |
+193,395
| New | +$3.75M |
|
3296
Investar Holding Corp
ISTR
$425M
| $2.24M | ﹤0.01% |
101,921
+1,004
| +1% | +$22.3K |
|
3297
Fathom Holdings
FTHM
$24.5M
| $2.23M | ﹤0.01% |
83,529
+3,520
| +4% | +$100K |
|
3298
Greenwich LifeSciences
GLSI
$240M
| $2.22M | ﹤0.01% |
56,919
+4,524
| +9% | +$189K |
|
|
VZIO
3299
DELISTED
VIZIO Holding Corp.
VZIO
| $2.21M | ﹤0.01% |
104,269
| – | – |
|
3300
BCB Bancorp
BCBP
$163M
| $2.21M | ﹤0.01% |
149,840
+11,116
| +8% | +$162K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.